Suppressive effects of red ginseng preparations on SW480 colon cancer xenografts in mice

Food Science and Biotechnology

Volumn 20, Issue 6, 2011, Pages 1649-1653

  Yang, Goeun ^a   Park, Dongsun ^a   Lee, Jinsoo ^a   Song, Byeng Sub ^b   Jeon, Tae Hwan ^b   Kang, Shin Jyung ^b   Jeon, Jeong Hee ^a   Shin, Sunhee ^a   Jeong, Heon Sang ^a   Lee, Hwa Jeong ^c   Kim, Yun Bae ^a  

^a Chungbuk National University   (South Korea)

^b Joongbu University   (South Korea)

^c Dongshin University   (South Korea)

Author keywords

anti tumor activity; colon cancer; immunomodulation; red ginseng preparation

Indexed keywords

ANTI-TUMOR ACTIVITIES; ANTI-TUMOR EFFICACY; COLON CANCER; CONTROL VALUES; CYTOTOXIC; CYTOTOXIC ACTIVITIES; DOSE-DEPENDENT MANNER; HUMAN COLON; IMMUNOMODULATION; IN-VITRO; IN-VIVO; NUDE MICE; RED GINSENG; TUMOR GROWTH;

CYTOTOXICITY; DISEASES; MAMMALS;

TUMORS;

MUS; MUS MUSCULUS; PANAX GINSENG;

EID: 84862930458     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10068-011-0227-y     Document Type: Article

References (32)

1. Iishi H, Tatsuta M, Baba M, Uehara H, Nakaizumi A, Shinkai K, Akedo H, Funai H, Ishiquro S, Kitagawa I. Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clin. Exp. Metastas 15: 603-611 (1997).
2. Kim SM, Lee SY, Cho JS, Son SM, Choi SS, Yun YP, Yoon DY, Oh KW, Jan SB, Hong JT. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-κB. Eur. J. Pharmacol. 631: 1-9 (2010).
3. Liu JW, Chen JX, Yu LH, Tian YX, Cui XY, Yan Q, Fu L. Inhibitory effect of ginsenoside-Rg3 on lung metastasis of mouse melanoma transfected with ribonuclease inhibitor. Chin. J. Oncol. 26: 722-725 (2004).
4. Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saili I, Tono-oka S, Samukawa K, Azuma I. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)-, and 20(S)-ginsenoside-Rg3, of red ginseng. Biol. Pharm. Bull. 18: 1197-1202 (1995).
5. Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, Im DS. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch. Pharm. Res. 27: 429-435 (2004).
6. Kim SM, Lee SY, Yuk DY, Moon DC, Choi SS, Kim Y, Han SB, Oh KW, Hong JT. Inhibition of NF-κB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch. Pharm. Res. 32: 755-765 (2009).
7. Park D, Bae DK, Jeon JH, Lee J, Oh N, Yang G, Yang YH, Kim TK, Song J, Lee SH, Song BS, Jeon TH, Kang SJ, Joo SS, Kim SU, Kim YB. Immunopotentiation and antitumor effects of a ginsenoside Rg3-fortified red ginseng preparation in mice bearing H460 lung cancer cells. Environ. Toxicol. Phar. 31: 397-405 (2011).
8. Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol. 50: 1155-1160 (1988).
9. Kim YS, Kim JJ, Cho KH, Jung WS, Moon SK, Park EK, Kim DH. Biotransformation of ginsenoside Rb1, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, glycyrrhizin, and baicalin by human microflora and its relation to cytotoxicity against tumor cells. J. Microbiol. Biotechn. 18: 1109-1114 (2008).
10. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab. Dispos. 31: 1065-1071 (2003).
11. Shin S, Jang JY, Park D, Yon JM, Baek IJ, Hwang BY, Nam SY, Yun YW, Kim KY, Joo SS, Kim YB. Korean red ginseng extract does not cause embryo-fetal death or abnormalities in mice. Birth Defects Res. B 89: 78-85 (2010).
12. Takino Y. Studies on the pharmacodynamics of ginsenoside-Rg1, -Rb1, and -Rb2 in rats. Yakugaku Zasshi 114: 550-564 (1994).
13. Wang CZ, Zhang B, Song WX, Wang A, Ni M, Luo X, Aung HH, Xie JT, Tong R, He TC, Yuan CS. Steamed American ginseng berry: Ginsenoside analyses and anticancer activities. J. Agr. Food Chem. 54: 9936-9942 (2006).
14. Kim WY, Kim JM, Han SB, Lee SK, Kim ND, Park MK, Kim CK, Park JH. Steaming of ginseng at high temperature enhances biological activity. J. Nat. Prod. 63: 1702-1704 (2000).
15. Seo JY, Lee JH, Kim NW, Her E, Chang SH, Ko NY, Yoo YH, Kim JW, Seo DW, Han JW, Kim YM, Choi WS. Effect of a fermented ginseng extract, BST204, on the expression of cyclooxygenase-2 in murine macrophages. Int. Immunopharmacol. 5: 929-936 (2005).
16. CIP1/WAF1. J. Cell. Physiol. 205: 107-113 (2005).
17. Chang DK, Kim YH, Byeon JS, Yang SK, Chung YW, Han DS, Kim SG, Kim TI, Kim WH, Jeen YT, Eun CS, Choi H, Choi KY, Song IS. The current status of ulcerative colitis-associated colorectal cancer in Korea: A KASID study. Korean J. Gastroenterol. 46: 276-282 (2005).
18. Lee SY, Kim GT, Roh SH, Song JS, Kim HJ, Hong SS, Kwon SW, Park JH. Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines. Biosci. Biotech. Bioch. 73: 811-816 (2009).
19. Park JW, Lee JC, Ann SA, Seo D, Choi WS, Yoo YH, Park SK, Choi JY, Um SH, Ahn SH, Han JW. A fermented ginseng extract, BST204, inhibits proliferation and motility of human colon cancer cells. Biomol. Ther. 19: 211-217 (2011).
20. Park HJ, Kim YB, Kang TS, Jung IS, Kim KY, Jeong HS. Immunomodulatory activities of oat bran extracts with different extraction conditions. Korean J. Food Sci. Technol. 37: 103-107 (2005).
21. Iwahashi T, Okochi E, Ariyoshi K, Watabe H, Amann E, Mori S, Tsuruo T, Ono K. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model. Cancer Res. 53: 5475-5482 (1993).
22. Wang CZ, Xie JT, Zhang B, Ni M, Fishbein A, Aung HH, Mehendale SR, Du W, He TC, Yuan CS. Chemopreventive effects of Panax notoginseng and its major constituents on SW480 human colorectal cancer cells. Int. J. Oncol. 31: 1149-1156 (2007).
23. Yang ZG, Sun HX, Ye YP. Ginsenoside Rd from Panax notoginseng is cytotoxic towards HeLa cancer cells and induces apoptosis. Chem. Biodivers. 3: 187-197 (2006).
24. Choi S, Oh JY, Kim SJ. Ginsenoside Rh2 induces Bcl-2 family proteins-mediated apoptosis in vitro and in xenografts in vivo models. J. Cell. Biochem. 112: 330-340 (2011).
25. Li B, Zhao J, Wang CZ, Searle J, He TC, Yuan CS, Du W. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett. 301: 185-192 (2011).
26. Zhu Q, Liu JY, Xu HW, Yang CM, Zhang AZ, Cui Y, Wang HB. Mechanism of counterattack of colorectal cancer cell by Fas/Fas ligand system. World J. Gastroenterol. 11: 6125-6129 (2005).
27. Bergmann-Leitner ES, Abrams SI. Influence of interferon γ on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attack. Cancer Immunol. Immun. 49: 193-207 (2000).
28. Chen J, Zhang H, Su F, Min J, Zhang J, Song E. Cytokine associated sensitivity of colon carcinoma cells to FasR-mediated cytotoxicity of CTL. Asian J. Surg. 25: 89-97 (2002).
29. Lee DK, Jang S, Kim MJ, Kim JH, Chung MJ, Kim KJ, Ha NJ. Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines. BMC Cancer 8: 310 (2008).
30. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem. Pharmacol. 58: 1685-1693 (1999).
31. Wang Y, Wang BX, Liu TH, Minami M, Nagata T, Ikejima T. Metabolism of ginsenoside Rg1 by intestinal bacteria. II. Immunological activity of ginsenoside Rg1 and Rh1. Acta Pharmacol. Sin. 21: 792-796 (2000).
32. Aung HH, Mehendale SR, Wang CZ, Xie JT, McEntee E, Yuan CS. Cisplatin's tumoricidal effect on human breast carcinoma MCF-7 cells was not attenuated by American ginseng. Cancer Chemoth. Pharm. 59: 364-374 (2007).